Integrum AB
STO:INTEG B
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| SE |
I
|
Integrum AB
STO:INTEG B
|
221.3m SEK |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.3B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.9B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.1B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.3B USD |
Loading...
|
Market Distribution
| Min | -5 565 412.8% |
| 30th Percentile | -5.3% |
| Median | 3% |
| 70th Percentile | 7.5% |
| Max | 12 228% |
Other Profitability Ratios
Integrum AB
Glance View
Integrum AB engages in the manufacturing of medical devices. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2017-05-15. The company provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The firm provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Integrum AB is -30.8%, which is below its 3-year median of -14.1%.
Over the last 3 years, Integrum AB’s Net Margin has decreased from 7.9% to -30.8%. During this period, it reached a low of -33.8% on Apr 30, 2025 and a high of 8.6% on Jan 31, 2024.
